DepoMorphine

DepoMorphine

DepoDur™ Pain management A sustained-release DepoFoam formulation of morphine used for acute post-surgical pain
References in periodicals archive ?
7 per cent as it started the approval process for a pain relief treatment called DepoMorphine.
For DepoTech additional risk factors include, but are not limited to, uncertainties involved in obtaining regulatory approval for DepoCyt, DepoMorphine or any of the company's potential products in the U.
DepoMorphine, currently in Phase II clinical trials, is a sustained-release formulation of morphine sulfate being developed to treat acute post-surgical pain.
Note to Editors: DepoFoam and DepoMorphine are trademarks of DepoTech Corporation.
In February 1998, the company reduced its workforce aimed at lessening operating expenses and focusing resources on the company's lead product, DepoCyt, as well as DepoMorphine and partnered funded feasibility programs.
Earlier this year, DepoTech began a Phase I clinical trial of DepoCyt in pediatric patients, and is conducting a Phase II study of DepoMorphine sustained-release encapsulated morphine sulfate to treat acute post-surgical pain.
In addition, the company began a Phase I clinical trial of DepoCyt in pediatric patients, and a Phase I study of DepoMorphine sustained-release encapsulated morphine sulfate to treat acute post-surgical pain.
Earlier this year, DepoTech began a Phase I clinical trial of DepoCyt in pediatric patients and a Phase I study of DepoMorphine sustained-release encapsulated morphine sulfate to treat acute post-surgical pain.
During the first quarter of 1997, DepoTech began two new Phase I clinical trials: DepoCyt in pediatric patients and DepoMorphine sustained-release encapsulated morphine sulfate to treat acute post-surgical pain.
NASDAQ:DEPO) Tuesday announced that it has begun a Phase I clinical trial of DepoMorphine sustained-release encapsulated morphine sulfate being developed to treat acute post-surgical pain.
Food and Drug Administration to begin a Phase I clinical trial of DepoMorphine, a sustained-release DepoFoam formulation of morphine used to treat acute post-surgical pain.
In addition to hip replacement surgery, these include major surgery, lower extremities orthopedic surgery and lower abdominal surgery, many of which could be candidates for DepoMorphine.